Brightsurf Science News & Current Events

March 29, 2008
New York-Presbyterian/Columbia physician-scientists present at ACC's 57th Annual Scientific Session
Physician-scientists from New York-Presbyterian Hospital/Columbia will present their latest research findings at the American College of Cardiology's 57th Annual Scientific Session.

New drug treatment could reduce ischaemic outcomes in patients with coronary stents
A new antiplatelet agent that provides higher levels of platelet inhibition than current standard therapies, could provide more consistent protection from ischemic events than standard treatment in patients who have had at least one coronary stent is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to